Skip Navigation

European Heart Journal 1995 16(Supplement J):78-83; doi:10.1093/eurheartj/16.suppl_J.78
Copyright © 1995 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mügge, A.
Right arrow Articles by Lichtlen, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mügge, A.
Right arrow Articles by Lichtlen, P. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 The European Society of Cardiology

Endothelial dysfunction in heart transplanted patients with graft vasculopathy

A. Mügge, R. P. Brandes, B. Heublein, C. Nolte, A. Haverich* and P. R. Lichtlen

Divisions of Cardiology Hannover, Germany
* Cardiac Surgery, Hannover Medical School Hannover, Germany

Correspondence: Andreas Mügge. MD, Division of Cardiology, Hannover Medical School, Konstanty-Gutschowstr. 8, D-30625 Hannover, Germany

The pathological mechanism of cardiac transplant vasculopathy (TVP) is uncertain. We tested the hypothesis that the endothelial function, in terms of the release of endothelium-derived relaxing factor, is impaired in patients with angiographic evidence of transplant vasculopathy.

In a pilot study, the effects of the substances used (substance P, acetylcholine, nitroglycerin) were assessed as regards tone of pre-contracted human coronary arteries in vitro, obtained from recipient hearts during cardiac transplantation. The study shows that substance P is a ‘pure’ endothelium-dependent dilator of epicardial human coronary arteries, whereas acetylcholine has a more complex effect on vascular tone involving both a direct effect on the endothelium and the smooth muscle cells.

In a second pilot study, the effects of intracoronary infusions of substance P (5-100 pmol.min-1) and acetylcholine (2-50 nmoLmin-1) on flow velocity were compared in 10 patients undergoing cardiac catheterization after heart transplantation. Flow velocity was determined by a 3F Doppler catheter placed into the proximal segment of the left anterior descending artery (LAD). Both drugs increased concentration-dependent flow velocity; substance P and acetylcholine maximally increased flow velocity by about 85 ± 24% and 143 ± 15%, respectively (P < 0·05).

In a third study, 23 patients undergoing diagnostic cardiac catheterization were included approximately 40 months after heart transplantation. Patients were classified into those with (n = 8) and those without (n = 15) angiographic evidence of TVP. Coronary flow velocity (by Doppler) and epicardial coronary diameter (by quantitative angiography) were determined after intracoronary injections of substance P (20 pmol), nitroglycerin (0·1 mg), and papaverine (8 mg). Substances were injected through the central lumen which was placed into the LAD. Increases in flow velocity in response to substance P were significantly less in patients with TVP than in patients without evidence of TVP. Moreover, flow-mediated vasodilation in response to papaverine was almost abolished in patients with TVP. Vasodilation in response to nitroglycerin and maximal increase in flow velocity in response to papaverine was similar in both groups

These results suggest that TVP is associated with endothelial dysfunction, which may contribute to the pathogenesis of TVP and its vascular complications.

Key Words: Endothelium • endothelium-derived relaxing factor • heart transplantation • transplant vasculopathy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
V. Marti, I. Romeo, R. Aymat, J. Garcia, P. Guiteras, M. Ballester, N. Aminian, J. M. Caralps, and J. M. Auge
Coronary endothelial dysfunction as a predictor of intimal thickening in the long term after heart transplantation
J. Thorac. Cardiovasc. Surg., December 1, 2001; 122(6): 1174 - 1180.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.